NASDAQ:AVDL
Avadel Pharmaceuticals plc Stock News
$18.82
+0.520 (+2.84%)
At Close: May 03, 2024
Avadel Pharmaceuticals plc (AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness and cataplex
Avadel Pharmaceuticals plc Annual Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
12:26pm, Saturday, 14'th Mar 2020
Shareholders in Avadel Pharmaceuticals plc (NASDAQ:AVDL) had a terrible week, as shares crashed 39% to US$6.01 in the...
Does Market Volatility Impact Avadel Pharmaceuticals plc's (NASDAQ:AVDL) Share Price?
10:56am, Friday, 13'th Mar 2020
If you own shares in Avadel Pharmaceuticals plc (NASDAQ:AVDL) then it's worth thinking about how it contributes to the...
Baird cuts view on Teladoc in premarket analyst action
12:11pm, Thursday, 12'th Mar 2020
Allakos (NASDAQ:ALLK) initiated with Underperform rating and $34 (42% downside risk) price target at SMBC Nikko.Avadel Pharmaceuticals (NASDAQ:AVDL) initiated with Buy rating and $14 (75% upside) pric
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
11:37am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) * Bicycle Therapeutics PLC (NASDAQ: BCYC) (reacte
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
08:14pm, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and vaccin
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
12:00am, Sunday, 08'th Mar 2020
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off.
The week was light on news flow, barring some smid-cap earnings and...
Best & Worst ADRs - Tuesday, March 3
01:16pm, Tuesday, 03'rd Mar 2020
The top-ranked sectors are healthcare, utilities, and technology. Services are neutral.
The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement
01:28pm, Tuesday, 25'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainst
6 Stock Charts To Watch: EGO, GILD, LAKE, SURF, TVIX, ZYXI6
12:00am, Tuesday, 25'th Feb 2020
Stocks Analysis by Harry Boxer covering: Gilead Sciences Inc, Lakeland Industries Inc, Eldorado Gold Corp, ProShares Ultra VIX Short-Term Futures ETF. Read Harry Boxer's latest article on Investing.co
94 Biggest Movers From Friday
09:53am, Monday, 24'th Feb 2020
Gainers
Trans World Entertainment Corporation (NASDAQ: TWMC) shares jumped 50.9% to close at $5.28 on Friday after the company disclosed that its subsidiary etailz entered into a...
3 Biotech Stocks That Soared This Week: Are They Buys?
12:34pm, Saturday, 22'nd Feb 2020
Can these high-flying biotech stocks keep up their sizzling momentum?
How a Small-Cap Fund Finds Exceptional Growth Overseas
06:38pm, Wednesday, 12'th Feb 2020
The Brown Capital Management International Small Company fund has outperformed peers and its benchmark over the past three years. Its secret is focusing on a company’s revenue growth to identify win
Strongbridge Biopharma: A Big Opportunity For Cushing's Syndrome Patients And For Investors
01:00pm, Thursday, 30'th Jan 2020
A major catalyst is approaching for SBBP with Phase 3 results for lead value driver, Recorlev, expected in 2Q or 3Q. Recorlev’s first Phase 3 trial, SONICS, had